Pharmacophore/receptor models for GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach
…, GR Wenger, R McKernan, JM Cook
Index: Yu, Shu; Ma, Chunrong; He, Xiaohui; McKernan, Ruth; Cook, James M. Medicinal Chemistry Research, 1999 , vol. 9, # 2 p. 71 - 88
Full Text: HTML
Citation Number: 143
Abstract
Pharmacophore/receptor models for three recombinant GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) have been established via an SAR ligand-mapping approach. This study was based on the affinities of 151 BzR ligands at five distinct (α1-3, 5, 6β3γ2) recombinant GABAA/BzR receptor subtypes from at least nine different structural families. Examination of the included volumes of the α1-, α5-, and α6-containing subtypes indicated ...
Related Articles:
Synthesis and biological evaluation of 1, 4-benzodiazepin-2-ones with antitrypanosomal activity
[Spencer, John; Rathnam, Rajendra P.; Harvey, Alan L.; Clements, Carol J.; Clark, Rachel L.; Barrett, Michael P.; Wong, Pui Ee; Male, Louise; Coles, Simon J.; MacKay, Simon P. Bioorganic and Medicinal Chemistry, 2011 , vol. 19, # 5 p. 1802 - 1815]